Aurora Cannabis (ACB) Stock Is Poised to Rebound
Aurora Cannabis (ACB) is well-positioned for the inevitable rebound in the cannabis sector, as it ramps up production capacity, boosts its GMP-compliant output, and develops a variety of derivative products to serve the Canadian and international markets.
By the end of June 2020, the company expects to have well over 625,000 kilograms in annual production capacity, and is now ready to increase the amount of GMP-compliant cannabis to send to the European market.
In this article we’re going to focus on the derivatives market in Canada, which while being approved of on October 17, 2019, won’t be available for sale until December 17, 2019 because of the required 60-day review period required by Canadian law.
– Read the entire article at Yahoo News.